Home  >  Products  >  MAFA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)) Blocking Peptide (100ug)
MAFA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)) Blocking Peptide (100ug)

MAFA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)) Blocking Peptide (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAFA antibody (Catalogue #: ARP47760_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP47760
Size: 100 ug
Weight: 37kDa
Gene: 389692
Format: Lyophilized powder
Target: MAFA is a transcription factor that binds RIPE3b, a conserved enhancer element that regulates pancreatic beta cell-specific expression of the insulin gene (INS).MAFA is a transcription factor that binds RIPE3b, a conserved enhancer element that regulates pancreatic beta cell-specific expression of the insulin gene (INS; MIM 176730) (Olbrot et al., 2002 [PubMed 12011435]).[supplied by OMIM]. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-1062 AC105118.23 99326-100387 c
Alternative names: RIPE3b1; hMafA